Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant. [electronic resource]
Producer: 20120521Description: 1294-304 p. digitalISSN:- 1537-6613
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Amino Acid Sequence
- CD8-Positive T-Lymphocytes -- physiology
- Cytomegalovirus Infections -- prevention & control
- Cytomegalovirus Vaccines -- administration & dosage
- Dose-Response Relationship, Immunologic
- Epitopes
- Female
- Humans
- Malaria Vaccines -- immunology
- Male
- Middle Aged
- Oligodeoxyribonucleotides -- administration & dosage
- Recombinant Proteins -- immunology
- Tetanus Toxoid -- administration & dosage
- Vaccines, Synthetic
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.